相关实验视频
Updated: Jul 2, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.4K
非侵入性实时葡萄糖监测在不久的将来
Irl B Hirsch1, Amir Tirosh2, Ami Navon3
1UW Medicine Diabetes Institute, School of Medicine, University of Washington, Seattle, Washington, USA.
Diabetes technology & therapeutics
|February 28, 2024
概括
这项研究验证了Gen III GWave,一种非侵入性血糖监测设备,与传统方法相比,显示出高精度和可重复性. 这项技术提供了有前途的实时,非侵入性血糖监测潜力.
科学领域:
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
- 糖尿病 技术 技术
背景情况:
- 持续葡萄糖监测 (CGM) 已经推进了糖尿病管理.
- 开发一种非侵入性血糖监测设备仍然是一个重要的研究目标.
- 之前的一项试点研究显示了GWave设备的有希望的相关性.
研究的目的:
- 在一个更大的队列中复制和验证一种新的非侵入性葡萄糖监测设备 (Gen III GWave) 的准确性.
- 为了评估与毛细血管血糖测量的一致性.
- 在诱导低血糖期间评估设备的可重现性和准确性.
主要方法:
- 使用了第三代可制造的GWave设备,具有标准化的传感器芯片.
- 75名受试者 (包括1型和2型糖尿病患者,非糖尿病孕妇和非糖尿病患者) 参与了这项研究.
- 使用克拉克错误网格,平均绝对相对差异和低血糖期间的比较来评估准确性;在两个设备之间测试了可重现性.
主要成果:
- 97%的第三代GWave读数位于克拉克错误网格的A区内,与参考血糖相比,绝对相对差异为6.7%.
- 在两个第三代GWave设备 (R2 = 0.95) 之间观察到高可重现性,在A区100%的值.
- 第三代GWave在低血糖期间准确地跟踪葡萄糖水平到42 mg/dL,在初始响应时间中表现优于CGM.
结论:
- 第三代GWave显示出作为潜在的突破性非侵入性葡萄糖监测技术的重大前景.
- 这些结果支持使用GWave技术实时非侵入性血糖监测的可行性.
- 未来的研究将集中在所有葡萄糖范围内的更大群体上,以进一步建立临床效用.
相关概念视频
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
Pulse rhythm
797
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
797
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154

